| CO71 Investigating the Secondary Care System Burden of Glycogen Storage Disease Type IA (GSDIA) Using the HES Database |
| Author(s): E Kruger
S Chavda
RN Gupta
V Valayannopoulos |
| Affiliations(s): Ultragenyx Pharmaceutical Inc., Novato, CA, USA
IQVIA, London, UK
Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA
|
Publication(s): Kruger, E et al.
Value in Health, Volume 25, Issue 7, S317
|
| Document Type(s): Abstract, Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Metabolic Disorders , Rare disease, Rare Diseases,
2022 |
|
L:
A: |
English
Burden of illness, clinical setting: Secondary care, Quality of life, |
|
 |
| |
| |
| English demographics and cost of HIV-associated comorbidities in individuals over the age of 35: an investigation using the Hospital Episode Statistics (HES) database |
| Author(s): Wild L, Smith A, Sathia L, Davies S, Fernandez DP, Lawrence D. |
| Affiliations(s): 1Gilead Sciences, London, UK, 2IQVIA, London, UK |
Publication(s): HIV MEDICINE 2018 Apr 1 (Vol. 19, pp. S76-S77).
|
| Document Type(s): Abstract, Poster, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
HIV AIDS,
2022 |
|
L:
A: |
English
Cost consequence, Cost of illness, Database Study, Population Based Study, |
|
|
| |
| |
| POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database
|
| Author(s): E Mary Babu
S Fermahan
S Chavda
M Chetty
S Navani
A Matthew
R Hudson |
| Affiliations(s): Sanofi, Reading, RDG, UK
IQVIA, London, UK |
Publication(s): Mary Babu, E et al.
Value in Health, Volume 25, Issue 1, S257
|
| Document Type(s): Abstract, Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Oncology,
2022 |
|
L:
A: |
English
Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis, |
|
|
| |
| |
| Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database |
| Author(s): C. Hopkins - S. Conlon - S. Chavda - R. Hudson - R. Rout |
| Affiliations(s): Guy's and St. Thomas' Hospital, Kings college, London, UK.
Sanofi Genzyme UK, Reading, UK.
IQVIA, London, UK. |
Publication(s): Rhinology 60-4: 252-260, 2022
|
| Document Type(s): Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Respiratory disease, Surgery,
2022 |
|
L:
A: |
English
Budget impact, Burden of illness, Cost analysis, Retrospective database analysis, |
|
|
| |
| |
| Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension
|
| Author(s): Allan Lawrie 1 2, Neil Hamilton 3, Steven Wood 2 4, Fernando Exposto 5, Ruvimbo Muzwidzwa 5, Louise Raiteri 5, Amélie Beaudet 6, Audrey Muller 6, Rafael Sauter 6, Nadia Pillai 6, David G Kiely |
| Affiliations(s): National Heart and Lung Institute, Imperial College London London UK.
2Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK.
3Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK.
4Scientific Computing, Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK.
5IQVIA London UK.
6Actelion Pharmaceuticals Ltd. Allschwil Switzerland.
7Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK. |
Publication(s): Pulm Circ. 2022 Oct; 12(4): e12136.
Published online 2022 Sep 30. doi: 10.1002/pul2.12136
|
| Document Type(s): Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2022 |
|
L:
A: |
English
Observational study, Retrospective cohort analysis, |
|
|
| |
| |
| PRS72 DRUG TREATMENT PATTERNS FOR PULMONARY ARTERIAL HYPERTENSION PATIENTS IN ENGLAND: A RETROSPECTIVE ANALYSIS USING HOSPITAL TREATMENT INSIGHTS DATABASE |
| Author(s): A. Beaudet
A. Yesufu-Udechuku
E.W. Davies
L.H. Taylor
S. Sikander-Rehman
R. Ogley
F. Exposto |
| Affiliations(s): Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland
Actelion Pharmaceuticals UK Ltd, London, UK
Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland
IQVIA, London, UK |
Publication(s): Open ArchiveDOI:https://doi.org/10.1016/j.jval.2019.09.2561
|
| Document Type(s): Poster, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Drug safety, Drug Utlization Study, Health status & patient reported outcomes,
2019 |
|
L:
A: |
English
Public Health, Real World Data, Retrospective cohort analysis, Retrospective Field Study, |
|
|
| |
| |
| Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
|
| Author(s): David G. Kiely,1,2,3 Orla Doyle,4 Edmund Drage,4 Harvey Jenner,4 Valentina Salvatelli,4 Flora A. Daniels,4 John Rigg,4 Claude Schmitt,5 Yevgeniy Samyshkin,5 Allan Lawrie,2,3,* and Rito Bergemann6,* |
| Affiliations(s): Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK
2Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK
3INSIGNEO, University of Sheffield, Sheffield, UK
4Real-World & Analytical Solutions, IQVIA, London, UK
5GSK, Middlesex, UK
6Evalueserve UK Ltd, London, UK
David G. Kiely, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK. Email: ten.shn@1yleik.divad Allan Lawrie, Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK |
Publication(s): Pulm Circ. 2019 Oct-Dec; 9(4): 2045894019890549.
Published online 2019 Nov 20. doi: 10.1177/2045894019890549
|
| Document Type(s): Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2019 |
|
L:
A: |
English
Machine Learning/Artificial Intelligence, |
|
|
| |
| |
| Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care
|
| Author(s): David R M Smith,F Christiaan K Dolk, Koen B Pouwels, Morag Christie, Julie V Robotham, Timo Smieszek
|
| Affiliations(s): Public Health England
|
| Publication(s): |
| Document Type(s): Article, |
| Countries: England, |
C:
Y: |
Miscellaneous,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Actual versus ?ideal? antibiotic prescribing for common conditions in English primary care
|
| Author(s): Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Julie V Robotham, Timo Smieszek
|
| Affiliations(s): Public Health England
|
| Publication(s): |
| Document Type(s): Article, Article, |
| Countries: England, |
C:
Y: |
Miscellaneous,
2018 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| Explaining variation in antibiotic prescribing between general practices in the UK
|
| Author(s): Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
|
| Affiliations(s): Public Health England
|
| Publication(s): |
| Document Type(s): Article, |
| Countries: England, |
C:
Y: |
2018 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 3 
|
